在南非胆囊癌患者中鉴定差异表达基因和相关免疫细胞类型

相关实验视频

Updated: Jul 29, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

747

John Devar1,2, Pavan Baichan1, Phelelani T Mpangase3

  • 1Department of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa.

Scientific reports
|November 11, 2025
PubMed
概括

这项研究揭示了南非胆囊癌 (GBC) 患者的关键基因表达变化,确定MUC16是显著过度表达的基因. 这些发现突显了免疫细胞失调,为这种侵略性癌症提供了潜在的治疗点.

关键词:
失调的路径被调节.胆囊癌是一种胆囊癌.免疫反应的免疫反应.16 亿元人民币16 亿元人民币文字转录学 (Transcriptomics) 是一个学科.

更多相关视频

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

688
Mining Spatial Transcriptomics Datasets using DeepSpaceDB10:16

Mining Spatial Transcriptomics Datasets using DeepSpaceDB

Published on: September 5, 2025

630

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...